Scholtz & Company’s CM Life Sciences III Inc. Unit CMLTU Stock Holding History

Scholtz & Company’s Portfolio CMLTU Stock Details CMLTU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-18,600	Closed	-$191K	–	76
2021 Q3	$191K	Sell	18,600 -3,550	-16%	-$37.1K	0.07%	66
2021 Q2	$243K	Buy	+22,150	New	+$239K	0.08%	65

Scholtz & Company's CMLTU Position: Q4 2021 in Review

Scholtz & Company sold out of CM Life Sciences III Inc. Unit (CMLTU) in Q4 2021, closing a stake of 18,600 shares — an estimated $191K sold.

Scholtz & Company first reported a position in CMLTU in Q2 2021 and held it in 2 quarters. The position peaked at $243K in Q2 2021. 0 funds tracked by Wall St. Rank hold CMLTU as of Q4 2021.

Scholtz & Company reported no remaining CM Life Sciences III Inc. Unit position as of Q4 2021 after selling out during the quarter.
Scholtz & Company sold 18,600 CM Life Sciences III Inc. Unit shares in Q4 2021, an estimated $191K.
Scholtz & Company first reported a position in CM Life Sciences III Inc. Unit in Q2 2021 and held it in 2 quarters.
Scholtz & Company's CM Life Sciences III Inc. Unit position peaked at $243K in Q2 2021.
0 funds tracked by Wall St. Rank held CM Life Sciences III Inc. Unit as of Q4 2021.

Based on Scholtz & Company's 13F filing for Q4 2021, filed 15 Feb 2022.